We are live on ! Find out more
KALA icon

KALA BIO
KALA

28 hedge funds and large institutions have $294K invested in KALA BIO in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.57% less ownership

Funds ownership: 0.58% → 0% (-0.57%)

3% less funds holding

Funds holding: 29 → 28 (-1)

81% less capital invested

Capital invested by funds: $1.58M → $294K (-$1.29M)

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$159K
2
Citadel Advisors
Citadel Advisors
Florida
+$95.3K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$84.5K
4
GCP
GSA Capital Partners
United Kingdom
+$35.7K
5
VF
Virtu Financial
New York
+$28.2K

Top Sellers

1
BBA
Baker Bros. Advisors
New York
-$1M
2
WP
Woodline Partners
California
-$125K
3
Jane Street
Jane Street
New York
-$45.8K
4
XT
XTX Topco
Cayman Islands
-$15.7K
5
Two Sigma Investments
Two Sigma Investments
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$72.3K +$159K +7,532 +921%
Citadel Advisors
2
Citadel Advisors
Florida
$48.8K +$95.3K +4,505 +399%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$45.2K +$84.5K +3,998 +327%
VF
4
Virtu Financial
New York
$26K +$28.2K +1,334 +78%
ACM
5
ADAR1 Capital Management
Texas
$24.5K – – –
GCP
6
GSA Capital Partners
United Kingdom
$15K +$35.7K +1,689 New
UBS Group
7
UBS Group
Switzerland
$11.6K +$18.2K +859 +180%
VCM
8
Vanguard Capital Management
Pennsylvania
$10.5K +$25.6K +1,211 New
Jane Street
9
Jane Street
New York
$6.23K -$45.8K -2,167 -75%
JP Morgan Chase
10
JP Morgan Chase
New York
$5.13K +$12.7K +599 +59,900%
VFT
11
Vanguard Fiduciary Trust
Pennsylvania
$5.13K +$12.5K +593 New
State Street
12
State Street
Massachusetts
$4.95K – – –
GPWM
13
Grant Private Wealth Management
California
$3.46K +$8.46K +400 New
GWM
14
Greenwich Wealth Management
Connecticut
$3K +$7.78K +368 New
LPL Financial
15
LPL Financial
California
$2.98K +$7.3K +345 New
Goldman Sachs
16
Goldman Sachs
New York
$2.43K +$5.94K +281 New
SG
17
StoneX Group
New York
$2.25K +$317 +15 +6%
Northern Trust
18
Northern Trust
Illinois
$2K – – –
BlackRock
19
BlackRock
New York
$1.87K -$4.48K -212 -50%
Morgan Stanley
20
Morgan Stanley
New York
$509 +$994 +47 +392%
VGA
21
Vanguard Global Advisers
Pennsylvania
$144 +$360 +17 New
MCM
22
MAI Capital Management
Ohio
$52 – – –
CVM
23
Cheviot Value Management
California
$26 – – –
HI
24
Harbour Investments
Wisconsin
$26 +$63 +3 New
SPIA
25
Steward Partners Investment Advisory
New York
$21 – – –
1
2

KALA Hedge Fund Activity: Q1 2026 in Review

28 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2026, worth a combined $294K — down 81% from $1.58M a quarter earlier.

Fund positioning in KALA was balanced in Q1 2026: 9 funds opened new positions, 9 closed out, 8 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $159K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1M sold.

  • 28 institutional investors held KALA BIO (KALA) as of Q1 2026, down from 29 in Q4 2025.
  • Funds reported $294K of KALA BIO stock for Q1 2026, down 81% quarter-over-quarter.
  • 9 funds opened new KALA BIO positions in Q1 2026 and 9 closed out, a net change of 0 holders.
  • The largest KALA BIO buyer in Q1 2026 was Renaissance Technologies, an estimated $159K added.
  • The largest KALA BIO seller in Q1 2026 was Baker Bros. Advisors, an estimated $1M sold.

Based on aggregated 13F filings for Q1 2026.